Blydt-Hansen, Ingrid, Michelle Bech, and Shannon Jackson. 2025. “Emicizumab in Severe Hemophilia A: Clinical and Patient Determinants of Transition Within a Standardized Program”. Journal of Hematology 14 (5): 257-61. https://doi.org/10.14740/jh2113.